SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )1
PROTEIN POLYMER TECHNOLOGIES, INC.
------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
------------------------------------------------------------------------------
(Title of Class of Securities)
743697 10 4
------------------------------------------------------------------------------
(CUSIP Number)
March 30, 2001
-----------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
--------
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No.743697 10 4 Page 2 of 6 Pages
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Johnson & Johnson
22-1024240
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY -----------------------------------------------------
EACH 6. SHARED VOTING POWER
REPORTING
PERSON 7,435,486 shares of Common Stock
WITH (includes shares issuable upon exercise of
warrants and conversion of Convertible
Preferred Stock)
----------------------------------------------------
7. SOLE DISPOSITIVE POWER
-0-
----------------------------------------------------
8. SHARED DISPOSITIVE POWER
7,435,486 shares of Common Stock
(includes shares issuable upon exercise of
warrants and conversion of Convertible
Preferred Stock)
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,435,486 shares of Common Stock
(includes shares issuable upon exercise of warrants and conversion of
Convertible Preferred Stock)
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
26.5%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
CUSIP No.743697 10 4 Page 3 of 6 Pages
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Johnson & Johnson Development Corporation
22-2007137
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY -----------------------------------------------------
EACH 6. SHARED VOTING POWER
REPORTING
PERSON 7,435,486 shares of Common Stock
WITH (includes shares issuable upon exercise of
warrants and conversion of Convertible
Preferred Stock)
-----------------------------------------------------
7. SOLE DISPOSITIVE POWER
-0-
-----------------------------------------------------
8. SHARED DISPOSITIVE POWER
7,435,486 shares of Common Stock
(includes shares issuable upon exercise of
warrants and conversion of Convertible
Preferred Stock)
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,435,486 shares of Common Stock
(includes shares issuable upon exercise of warrants and conversion of
Convertible Preferred Stock)
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
26.5%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
CUSIP No.743697 10 4 Page 4 of 6 Pages
Schedule 13G
------------
ITEM 1(a) - NAME OF ISSUER:
Protein Polymer Technologies Inc
ITEM 1(b) - ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
10655 Sorrento Valley Road
San Diego, CA 92121
ITEM 2(a) - NAME OF PERSON FILING:
This statement is being filed by Johnson & Johnson, a New Jersey
corporation ("J&J"), and Johnson & Johnson Development Corporation, a New Jersey
corporation ("JJDC"). JJDC is a wholly-owned subsidiary of J&J. The securities
reported herein as being held by J&J and JJDC are directly beneficially owned by
JJDC. J&J may be deemed to indirectly beneficially own the securities that are
directly beneficially owned by JJDC.
ITEM 2(b) - ADDRESS OF PRINCIPAL BUSINESS OFFICE:
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
ITEM 2(c) - CITIZENSHIP:
J&J: New Jersey
JJDC: New Jersey
ITEM 2(d) - TITLE OF CLASS OF SECURITIES:
Common Stock, $.01 par value per share ("Common Stock")
ITEM 2(e) - CUSIP NUMBER:
743697 10 4
ITEM 3 - STATEMENTS FILED PURSUANT TO RULES 13D-1(B) OR
13D-2(B) OR (C):
Not applicable.
ITEM 4 - OWNERSHIP:
(a) Amount Beneficially Owned:
J&J: 7,435,486 shares of Common Stock (includes shares
issuable upon exercise of warrants and conversion
of Convertible Preferred Stock)
JJDC: 7,435,486 shares of Common Stock (includes shares
issuable upon exercise of warrants and conversion
of Convertible Preferred Stock)
(b) Percent of Class:
J&J: 26.5%
JJDC: 26.5%
CUSIP No.743697 10 4 Page 5 of 6 Pages
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: -0-
(ii) shared power to vote or to direct the vote:
J&J: 7,435,486 shares of Common Stock (includes shares
issuable upon exercise of warrants and conversion
of Convertible Preferred Stock)
JJDC: 7,435,486 shares of Common Stock (includes shares
issuable upon exercise of warrants and conversion
of Convertible Preferred Stock)
(iii) sole power to dispose or to direct
the disposition of: -0-
(iv) shared power to dispose or to direct the disposition of:
J&J: 7,435,486 shares of Common Stock (includes shares
issuable upon exercise of warrants and conversion
of Convertible Preferred Stock)
JJDC: 7,435,486 shares of Common Stock (includes shares
issuable upon exercise of warrants and conversion
of Convertible Preferred Stock)
ITEM 5 - OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Not applicable.
ITEM 6 - OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
Not applicable.
ITEM 7 - IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY:
Not applicable.
ITEM 8 - IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
Not applicable.
ITEM 9 - NOTICE OF DISSOLUTION OF GROUP:
Not applicable.
ITEM 10 - CERTIFICATION:
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
CUSIP No.743697 10 4 Page 6 of 6 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
JOHNSON & JOHNSON
By /s/ MICHAEL H. ULLMANN
------------------------------------
Name: Michael H. Ullmann
Title: Secretary
Dated: February 13, 2002
JOHNSON & JOHNSON DEVELOPMENT CORPORATION
By /s/ ERIC B. JUNG
------------------------------------
Name: Eric B. Jung
Title: Secretary
Dated: February 13, 2002